Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 343-345

  Horra, Alfons ^a   Salazar, Juliana ^a   Ferré, Raimon ^a   Vallvé, Joan Carles ^a   Guardiola, Montse ^a   Rosales, Roser ^a   Masana, Lluís ^a   Ribalta, Josep ^a  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

Author keywords

Adipose tissue; FCHL; FOXC2; Gene expression; Lipoproteins; Lymphatic system; Prox 1

Indexed keywords

COMPLEMENTARY DNA; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ABDOMINAL WALL; ADIPOSE TISSUE; ADULT; BIOPSY TECHNIQUE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LETTER; LYMPH VESSEL; LYMPHATIC SYSTEM; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ADULT; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LYMPHATIC SYSTEM; MALE; TUMOR SUPPRESSOR PROTEINS;

EID: 70349525063     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.026     Document Type: Letter

References (16)

1. Ayyobi A.F., and Brunzell J.D. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am J Cardiol 92 (2003) 27J-33J
2. Castro Cabezas M., de Bruin T.W., de Valk H.W., et al. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 92 (1993) 160-168
3. Harvey N.L., Srinivasan R.S., Dillard M.E., et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 37 (2005) 1072-1081
4. Cederberg A., Gronning L.M., Ahren B., et al. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106 (2001) 563-573
5. Pajukanta P., Allayee H., Krass K.L., et al. Combined analysis of genome scans of Dutch and finish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q. Am J Hum Genet 72 (2003) 903-917
6. Johnson N.C., Dillard M.E., Baluk P., et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 22 (2008) 3282-3291
7. Nanjee M.N., Cooke C.J., Olszewski W.L., and Miller N.E. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. J Lipid Res 41 (2000) 1317-1327
8. Cooke C.J., Nanjee M.N., Stepanova I.P., Olszewski W.L., and Miller N.E. Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise. Atherosclerosis 173 (2004) 39-45
9. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
10. Sosa-Pineda B., Wigle J.T., and Oliver G. Hepatocyte migration during liver development requires Prox1. Nat Genet 25 (2000) 254-255
11. Hong Y.K., Harvey N., Noh Y.H., et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225 (2002) 351-357
12. Burke Z., and Oliver G. Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. Mech Dev 118 (2002) 147-155
13. Wang J., Kilic G., Aydin M., et al. Prox1 activity controls pancreas morphogenesis and participates in the production of "secondary transition" pancreatic endocrine cells. Dev Biol 286 (2005) 182-194
14. Kume T., Deng K., and Hogan B.L. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 127 (2000) 1387-1395
15. Carlsson E., Groop L., and Ridderstrale M. Role of the FOXC2-512C > T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome. Int J Obes (Lond) 29 (2005) 268-274
16. Fujita H., Kang M., Eren M., et al. Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression. Circ Res 98 (2006) 626-634